N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
2022 · Molecular Cancer · 98 citations
https://doi.org/10.1186/s12943-022-01549-1
H
Huan Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
1.2K
Citations
20
h-index
29
i10-index
Huan Wang is an academic researcher from Gannan Normal University. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related molecular mechanisms research & Circular RNAs in diseases. The author has an h-index of 20, co-authored 41 publications.
ORCID: 0000-0001-9409-5984Papers by this author
worksRole of noncoding RNA in drug resistance of prostate cancer
2021 · Cell Death and Disease · 64 citations
https://doi.org/10.1038/s41419-021-03854-x
Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study
2020 · Cancer Immunology Immunotherapy · 31 citations
https://doi.org/10.1007/s00262-020-02738-x
Additional file 1 of N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19745056
A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24588634
Discovery of Semiliquidambar cathayensis and its parent species as potent anti-osteoarthritic agents through integrated in vitro, in vivo and network pharmacological analyses
2025 · Industrial Crops and Products · 0 citations
https://doi.org/10.1016/j.indcrop.2025.121604
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat